Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity

Behavioural Brain Research

Volumn 107, Issue 1-2, 2000, Pages 111-121

  Lacroix, Laurent ^a   Broersen, Laus M ^b   Feldon, Joram ^a   Weiner, Ina ^c  

^a SWISS FEDERAL INSTITUTE OF TECHNOLOGY   (Switzerland)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Amphetamine; Animal model; Apomorphine; Cis flupenthixol; Dopamine; Latent inhibition; Locomotor activity; Medial prefrontal cortex; Prepulse inhibition; Rat; Schizophrenia

Indexed keywords

AMPHETAMINE; APOMORPHINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FLUPENTIXOL;

ANIMAL MODEL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG SENSITIVITY; INTRACEREBRAL DRUG ADMINISTRATION; LATENT INHIBITION; LOCOMOTION; MALE; NONHUMAN; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; REVIEW; SCHIZOPHRENIA;

EID: 0033991027     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(99)00118-7     Document Type: Article

References (96)

1. Andreasen N.C., Rezai K., Alliger R., Swayze V.W., Flaum M., Kirchner P., Cohen G., Oleary D.S. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia-assessment with xenon-133 single-photon emission computed tomography and the Tower of London. Arch. Gen. Psychiatr. 49:1992;943-958.
2. Anscombe F. The disorder of consciousness in schizophrenia. Schizophr. Bull. 13:1987;241-260.
3. Baruch I., Hemsley D., Gray J.A. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J. Nerv. Ment. Dis. 176:1988;598-606.
4. Berretta S., Robertson H.A., Graybiel A.M. Neurochemically specialized projection neurons of the striatum respond differentially to psychomotor stimulants. Prog. Brain Res. 99:1993;201-205.
5. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
6. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Arch. Gen. Psychiatr. 47:1990;181-188.
7. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatr. 49:1992;206-215.
8. Broersen LM, Feldon J, Weiner I. Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion. Neuroscience (in press).
9. Broersen L.M., Heinsbroek R.P.W., de Bruin J.P.C., Joosten R.N.J.M.A., van Hest A., Olivier B. Effects of local application of dopaminergic drugs into the dorsal part of the medial prefrontal cortex of rats in a delayed matching to position task: comparison with local cholinergic blockade. Brain Res. 645(1-2):1994;113-122.
10. Broersen L.M., Heinsbroek R.P.W., de Bruin J.P.C., Olivier B. Effects of local application of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition. Biol. Psychiatr. 40:1996;1083-1090.
11. Broersen L.M., Heinsbroek R.P.W., de Bruin J.P.C., Uylings H.B.M., Olivier B. The role of the medial prefrontal cortex of rats in short-term memory functioning: further support for involvement of cholinergic, rather than dopaminergic mechanisms. Brain Res. 674(2):1995;221-229.
12. Bubser M., Koch M. Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex. Psychopharmacology. 113:1994;487-492.
13. Bubser M., Schmidt W.J. Injection of apomorphine into the medial prefrontal cortex of the rat increases haloperidol-induced catalepsy. Biol. Psychiatr. 36:1994;64-67.
14. Carter C.J., Pycock C.J. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat. Brain Res. 192:1980;163-176.
15. Deutch A. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J. Neural. Trans. (Suppl.). 36:1992;61-89.
16. Deutch A.Y., Cameron D.S. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience. 46:1992;49-56.
17. Deutch A.Y., Clark W.A., Roth R.H. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res. 521:1990;311-315.
18. Druhan J.P., Geyer M.A., Valentino R.J. Lack of sensitization to the effects of D-amphetamine and apomorphine on sensorimotor gating in rats. Psychopharmacology. 135(3):1998;296-304.
19. Dunn L.A., Atwater G.E., Kilts C.D. Effects of antipsychotic drugs on latent inhibition-sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology. 112(2-3):1993;315-323.
20. Duvauchelle C.L., Levitin M, MacConell L.A., Lee L.K., Ettenberg A. Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward. Brain Res. 576:1992;104-110.
21. Ellenbroek B.A., Budde S., Cools A.R. Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience. 75:1996;535-542.
22. Feldon J., Shofel A., Weiner I. Latent inhibition is unaffected by direct dopamine agonists. Pharmacol. Biochem. Behav. 38:1991;309-314.
23. Feldon J., Weiner I. The latent inhibition model of schizophrenic attention disorder: haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli. Biol. Psychiatr. 29:1991;635-646.
24. Geyer MA, Russo PV, Segal DS, Kuczenski R. Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats. Pharmacol Biochem Behav, 1987.
25. Gosselin G., Oberling P., Di Scala G. Antagonism of amphetamine-induced disruption of latent inhibition by the atypical antipsychotic olanzapine in rats. Behav. Pharmacol. 7(8):1996;820-826.
26. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 41:1991;1-24.
27. Gray J.A., Moran P.M., Grigoryan G., Peters S.L., Young A.M.J., Joseph M.H. Latent inhibition: the nucleus accumbens connection revisited. Behav. Brain Res. 88:1997;27-34.
28. Gray N.S., Hemsley D.R., Gray J.A. Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurol. Psychiat. Brain Res. 1:1992;83-89.
29. Gray N.S., Pilowsky L.S., Gray J.A., Kerwin R.W. Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophr. Res. 17:1995;95-107.
30. Groenewegen H.J., Wright C.I., Beijer A.V.J. The nucleus accumbens: gateway for limbic structures to reach the motor system? Prog. Brain Res. 107:1996;485-521.
31. Hart S., Zreik M., Carper R., Swerdlow N.R. Localizing haloperidol effects on sensorimotor gating in a predictive model of antipsychotic potency. Pharmacol. Biochem. Behav. 61:1998;113-119.
32. Hoffman H.S., Ison J.R. Reflex modification in the domain of startle. 1. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol. Rev. 87:1980;175-189.
33. Inoue T., Tsuchiya K., Koyama T. Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmacol. Biochem. Behav. 49:1994;911-920.
34. Jaskiw G.E., Karoum F., Freed W.J., Phillips I., Kleinman J.E., Weinberger D.R. Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat. Brain. Res. 534:1990;263-272.
35. Jaskiw G.E., Weinberger D.R., Crawley J.N. Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in microdialysate from the caudate nucleus. Biol. Psychiatr. 29:1991;703-706.
36. Joel D., Weiner I., Feldon J. Electrolytic lesions of the medial prefrontal cortex in rats disrupt performance of an analog of the Wisconsin Card Sorting Test, but do not disrupt latent inhibition: implications for animal models of schizophrenia. Behav. Brain Res. 85:1997;187-201.
37. Joyce E.M., Stinus L., Iversen S.D. Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug induced activity. Neuropharmacology. 22:1983;1141-1145.
38. Killcross A.S., Dickinson A., Robbins T.W. Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction. Psychopharmacology. 115:1994;185-195.
39. Killcross A.S., Dickinson A., Robbins T.W. Effects of the neuroleptic alpha-flupenthixol on latent inhibition in aversively-and appetitively-motivated paradigms: evidence for dopamine-reinforcer interactions. Psychopharmacology. 115:1994;196-205.
40. Killcross A.S., Robbins T.W. Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology. 110:1993;479-489.
41. King D., Zigmond M.J., Finlay J.M. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience. 77:1997;141-153.
42. Koch M., Bubser M. Deficient sensorimotor gating after 6-hydroxydopamine lesion of the rat medial prefrontal cortex is reversed by haloperidol. Eur. J. Neurosci. 6:1994;1837-1845.
43. Kuczenski R. Biochemical actions of amphetamine and other stimulants. Creese I Stimulants: Neurochemical, Behavioral and Clinical Perspectives. 1983;31-62 Raven Press, New York.
44. Kuczenski R., Segal D. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J. Neurosci. 9:1989;2051-2065.
45. Lacroix L., Broersen L.M., Weiner I., Feldon J. The effect of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience. 84:1998;431-442.
46. Louilot A., Le Moal M., Simon H. Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens: an in vivo voltammetric study. Neuroscience. 29:1989;45-56.
47. Lubow R.E. Latent inhibition. Psychol. Bull. 79:1973;398-407.
48. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology. 94:1988;507-514.
49. Mayerhoff D.I., Loebel A.D., Alvir J.M.J., Szymanski S.R., Geisler S.H., Borenstein M., Lieberman J.A. The deficit state in first-episode schizophrenia. Am. J. Psychiatr. 151:1994;1417-1422.
50. McGhie A., Chapman J. Disorders of attention and perception in early schizophrenia. Brit. J. Med. Psychol. 34:1961;103-116.
51. Mitchell J.B., Gratton A. Partial dopamine depletion of the prefrontal cortex leads to enhanced mesolimbic dopamine release elicited by repeated exposure to naturally reinforcing stimuli. J. Neurosci. 12:1992;3609-3618.
52. Moran P.M., Fischer T.R., Hitchcock J.M., Moser P.C. Effects of clozapine on latent inhibition in the rat. Behav. Pharmacol. 7(1):1996;42-48.
53. Morency M.A., Stewart R.J., Beninger R.J. Effects of unilateral microinjections of sulpiride into the medial prefrontal cortex on circling behavior of rats. Prog. Neuro. Psych. Biol. Psychiatr. 9:1985;735-738.
54. Morency M.A., Stewart R.J., Beninger R.J. Circling behavior following unilateral microinjections of cocaine into the medial prefrontal cortex: dopaminergic or local anesthetic effect? J. Neurosci. 7:1987;812-818.
55. Murphy B.L., Arnsten A.F.T., Goldman-Rakic P.S., Roth R.H. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Natl. Acad. Sci. USA. 93:1996;1325-1329.
56. Myers R.D. Handbook of Drug and Chemical Stimulation of the Brain. 1974;Van Nostrand Reinhold, New York.
57. Nuechterlein K.H., Dawson M.E. Information processing and attentional functioning in the developmental course of the schizophrenic disorder. Schizophr. Bull. 10:1984;160-203.
58. Paul M.L., Graybiel A.M., David J.-C., Robertson H.A. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12:1992;3729-3742.
59. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, San Diego.
60. Pycock C.J., Carter C.J., Kerwin R.W. Effects of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. J. Neurochem. 34:1980;91-99.
61. Radcliffe R.A., Erwin V.G. Alterations in locomotor activity after microinjections of GBR-12909, selective dopamine antagonists or neurotensin into the medial prefrontal cortex. J. Pharmacol. Exp. Ther. 277:1996;1467-1476.
62. Robbins T.W. The case for frontostriatal dysfunction in schizophrenia. Schizophr. Bull. 16:1990;391-402.
63. Roberts A.C., De Salvia M.A., Wilkinson L.S., Collins P., Muir J.L., Everitt B.J., Robbins T.W. 6-hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J. Neurosci. 14 (5 Part 1):1994;2531-2544.
64. Rosin D.L., Clark W.A., Goldstein M., Roth R.H., Deutch A.Y. Effects of 6-OHDA lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Neuroscience. 48:1992;831-839.
65. Routtenberg A. Intracranial chemical injection and behavior: a critical review. Behav. Biol. 7:1972;601-641.
66. Sahakian B.J., Sarna G.S., Kantamaneni B.D., Jackson A., Hutson P.H., Curzon G. Association between learning and cortical catecholamines in non-drug-treated rats. Psychopharmacology. 86:1985;339-343.
67. Smith I.D., Sutton M.A., Beninger R.J. Rotational bias in intact rats following intrastriatal injections of dopaminergic drugs. Pharmacol. Biochem. Behav. 58:1997;431-441.
68. Solomon P.R., Crider A., Winkelman J.W., Turi A., Kamer R.M., Kaplan L.J. Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder. Biol. Psychiatr. 16:1981;519-537.
69. Solomon P.R., Staton D.M. Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus. Biol. Psychiatr. 17:1982;743-756.
70. Stewart R.J., Morency M.A., Beninger R.J. Differential effects of intrafrontocortical microinjections of dopamine agonists and antagonists on circling behavior of rats. Behav. Brain Res. 17:1985;67-72.
71. Swerdlow N.R., Braff D.L., Geyer M.A., Koob G.F. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol. Psychiatr. 21:1986;23-33.
72. Swerdlow N.R., Braff D.L., Hartston H., Perry W., Geyer M.A. Latent inhibition in schizophrenia. Schizophr. Res. 20:1996;91-103.
73. Swerdlow N.R., Braff D.L., Masten V.L., Geyer M.A. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology. 101:1990;414-420.
74. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch. Gen. Psychiatr. 51:1994;139-154.
75. Swerdlow N.R., Caine S.B., Geyer M.A. Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology. 108:1992;189-195.
76. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr. Bull. 24:1998;285-301.
77. Swerdlow N.R., Lipska B.K., Weinberger D.R., Braff D.L., Jaskiw G.E., Geyer M.A. Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology. 122:1995;27-34.
78. Swerdlow N.R., Mansbach R.S., Geyer M.A., Pulvirenti L., Koob G.F., Braff D.L. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology. 100:1990;413-416.
79. Taber M.T., Fibiger H.C. Electrical stimulation of the medial prefrontal cortex increases dopamine release in the striatum. Neuropsychopharmacology. 9:1993;271-275.
80. Tai C.-T., Cassaday H.J., Feldon J., Rawlins J.N.P. Both electrolytic and excitotoxic lesions of nucleus accumbens disrupt latent inhibition of learning in rats. Neurobiol. Learn. Mem. 64:1995;36-48.
81. Thompson T.L., Moss R.L. In vivo stimulated dopamine release in the nucleus accumbens: modulation by the prefrontal cortex. Brain. Res. 686:1995;93-98.
82. Vaitl D., Lipp O.V. Latent inhibition and autonomic responses: a psychophysiological approach. Behav. Brain. Res. 88:1997;85-93.
83. Van Eden C.G., Lamme V.A.F., Uylings H.B.M. Heterotopic cortical afferents to the medial prefrontal cortex in the rat. A combined retrograde and anterograde tracer study. Eur. J. Neurosci. 4:1992;77-97.
84. Vezina P., Blanc G., Glowinski J., Tassin J.P. Opposed behavioural outputs of increased dopamine transmission in prefrontocortical and subcortical areas: a role for the cortical D-1 dopamine receptor. Eur. J. Neurosci. 3:1991;1001-1007.
85. Wan F.J., Swerdlow N.R. Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology. 113:1994;103-109.
86. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatr. 44:1987;660-669.
87. Weiner I., Feldon J. Facilitation of latent inhibition by haloperidol in rats. Psychopharmacology. 91:1987;248-253.
88. Weiner I., Lubow R.E., Feldon J. Chronic amphetamine and latent inhibition. Behav. Brain. Res. 2:1981;285-286.
89. Weiner I., Lubow R.E., Feldon J. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology. 83:1984;194-199.
90. Weiner I., Lubow R.E., Feldon J. Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol. Biochem. Behav. 30:1988;871-878.
91. Westerink B.H.C., Spaan S.J. On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain. J. Neurochem. 38:1982;680-686.
92. Wilkinson L.S., Humby T., Killcross A.S., Torres E.M., Everitt B.J., Robbins T.W. Dissociations in dopamine release in medial prefrontal cortex and ventral striatum during the acquisition and extinction of classical aversive conditioning in the rat. Eur. J. Neurosci. 10:1998;1019-1026.
93. Williams G.V., Goldman-Rakic P.S. Modulation of memory fields by dopamine d1 receptors in prefrontal cortex. Nature. 376:1995;572-575.
94. Wolkin A., Sanifilipo M., Wolf A.P., Angrist B., Brodie J.D., Rotrosen J. Negative symptoms and hypofrontality in chronic schizophrenia. Arch. Gen. Psychiatr. 49:1992;959-965.
95. Zetterstrom T., Sharp T., Marsden C.A., Ungerstedt U. In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after D-amphetamine. J. Neurochem. 41:1983;1769-1773.
96. Zetterstrom T., Ungerstedt U. Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis. Eur. J. Pharmacol. 97:1984;29-36.